Background {#Sec1}
==========

Typical acquisition protocols for coronary computed tomography angiography (CCTA) is to obtain all phases of the cardiac cycle (RR-interval) allowing calculation of ejection fraction (EF) simultaneously with plaque burden \[[@CR1], [@CR2]\]. Recently increased concern for radiation exposure has led to a shift towards adopting dose modulation acquisition protocols for CCTA imaging \[[@CR3], [@CR4]\]. These protocols target specific phases of the RR-interval that have been shown to produce the best coronary image quality, and predominantly unaffected by motion artifact.

Previous experience from electron beam computed tomography (EBCT) and MDCT, using retrospective overlapping helical acquisition (RS-OHA) technique, showed that image quality is best acquired at certain time phases of the cardiac cycle (referred to as the percentage time of the R--R interval) when the coronary arteries, especially the right coronary artery (RCA), are near still \[[@CR3], [@CR5], [@CR6]\]. In all these studies, the 35 or 75% phases have shown to produce the most interpretable images \[[@CR7]--[@CR9]\]. However, the problem lies in volume measurement for end diastolic volume (EDV) and end systolic volume (ESV). Whereas ESV is the LV volume measured at the 35% phase, in more that 90% of the cases, the LV volume at 75% phase is never the actual EDV \[[@CR3]\]. The latter is best measured at the 95% phase. Consequently, the adoption of prospective imaging protocols has made determining the true EDV on CT impossible, as images are only obtained at one phase range, which does not include the 95% phase.

In this study, we aim to describe the phase of the R--R interval in the cardiac cycle that produced the optimal images in regards to RCA motion for a large cohort of 1,085 patients undergoing RS-OHA 64-MDCT, gantry rotation speed 0.35 s, with various heart rates. We also studied whether the 75% phase can serve as a surrogate for end-diastole and whether it is accurate enough for EF calculations, with 35% phase as the end systolic phase of the cardiac cycle.

Methods {#Sec2}
=======

Patient population {#Sec3}
------------------

The study includes data acquired from patients referred to our center (Los Angeles Biomedical Research Institute at Harbor-UCLA) for cardiac computed tomography angiography (CCTA). 1,085 consecutive patients with no history of coronary artery disease (CAD) undergoing 64 detector row MDCT angiography from September, 2006 to September, 2008 were included. The various indications for the study included: chest pain, shortness of breath, abnormal or equivocal stress test, cardiomyopathy, congestive heart failure, or syncope. Patients were excluded if found to have an irregular heart rate, allergy to contrast medium or impaired renal function. This study was approved by the local Institutional Review Board of our hospital.

Patient preparation {#Sec4}
-------------------

The patients were prepared in usual manner as described in earlier studies. In brief, patients received explanation about the procedure and informed consent was obtained. Upon arrival to our center, if the patient's base line HR was more than 80 bpm, 100 mg of atenolol was given orally and was asked to wait for 1 h. Alternatively, if the HR \< 80 bpm the patient was attached to the scanner without any delay. On the scanner, if the HR was \>60 bpm, intravenous (IV) metoprolol was administered in doses of 5 mg every 1 min until the HR was brought below 60 bpm or a total IV dose of 40 mg was given or the systolic blood pressure (SBP) dropped to \<90 mm Hg. Intravenous diltiazem was also used to complement the beta blocker if needed. Three phase injection using a Dual Barrel Injector with contrast/saline mix was administered intravenously as follows: 5 ml/s for 12 s (60 ml contrast), then 5 ml/s for 10 s (50--20 ml contrast plus 30 ml saline) and finally 5 ml/s for 4 s (20 ml of saline), injection protocols were varied based upon patient characteristics (length of heart, heart rate, body habitus).

Image acquisition and analysis {#Sec5}
------------------------------

Computed tomography angiography study was completed with 64-MDCT (Light Speed VCT, General Electric Medical System, Milwaukee, WI). The technique of the cardiac retrospective overlapping helical acquisition was completed utilizing a 0.35-s scan gantry rotation speed and a 64 × 0.625 mm slices. The pitch was automatically determined by the heart rate. The reconstruction field of view (SFOV) was small (12--17 cm, mean 15 cm) with a voxel size in 0.29 × 0.29 × 0.6 mm³. An energy setting of 120 kVp was used for patients weighing ≥85 kg. For patients who were \<85 kg, an energy setting of 100 kVp was selected. The tube current or mA was 200--800; also determined based on the body habitus. The image reconstructions were done using 10 phases in 10% of each RR interval. The total scan time was about 5--6 s. Images were reviewed in consensus by two interpretors (MJB and SM) with each having more than 10 years experience in reading cardiac CTAs.

Of the 10 phases, the phase that provided the best image of the segment with minimal motion of mid portion of RCA was referred to as the optimal phase. The mid portion of the RCA was chosen as reference point in axial images, because this segment is most likely to be affected by the cardiac motion causing image artifact. Motion distance was defined as the distance from the center of the artery lumen to the tail of the motion. The grading system is shown in (Table [1](#Tab1){ref-type="table"}; Fig. [1](#Fig1){ref-type="fig"}).Table 1Grades of RCA motion accessed from center of vessel to tail of motion segmentGrade 1\<1 mm motion distanceGrade 21--3 mm motion distanceGrade 3\>3 mm motion distance in at least 3 slices (this was considered also as a study failure)Fig. 1Grades 1, 2 and 3 of right coronary artery motion, respectively

We randomly selected a cohort of 216 patients who met the following criteria: (1) All patients had excellent image quality obtained using the retrospective helical acquisition protocol with 10 sets of images present; (2) patients with EF \< 50% were excluded. In this group of patients an independent interpretor (SM) measured ejection fraction using 35 and 95% of cardiac cycle as well as using 35 and 95% of the cardiac cycle as end systolic and end diastolic phases, respectively using the 'Auto Ejection Fraction' protocol on the workstation (Advantage 4.4, General Electric, Milwaulkee WI).

Statistical analysis {#Sec6}
--------------------

The data was analyzed using SPSS 15 statistical software. Categorical variables were analyzed using Chi-Square test and Continuous variables using student *t*-test. Area under the curve (AUC) was constructed to access image quality for HR \> 60 bpm at various phases of RR interval.

The means of two independent variables, each with its own set of continuous data points, were compared using Student's *t*-test or Mann--Whitney *U*-test as statistically necessary. Similarly, the Spearman's or Pearson's correlation tests were used to determine the association between continuous variables. For ejection fraction correlation, a linear regression model was used to determine statistically significant predictors of the continuous dependent variable (EDV or LVEF). A regression model residuals analysis including a regression studentized residual plot versus regression standardized predicted value plots and a regression standardized residual histogram distribution curve were used to test the regression model assumptions hold. For all analyses, a criterion for statistical significance was set at a 2-tailed *P* value \< 0.05.

Results {#Sec7}
=======

Optimal image quality with respect to RCA motion {#Sec8}
------------------------------------------------

In this cohort of 1,085 patients, 757 patients were males (69.76%) and the average HR of this group was 56.72 ± 9.43 beats per minute (range 33--140). (Table [2](#Tab2){ref-type="table"}). The distribution of image quality was 958 (88.3%) Grade 1, 113 (10.42%) Grade 2 and 14 (1.29%) Grade 3 images. The distribution of optimal images (Grades 1 and 2) was stratified based on HR and phase at which it was acquired (Table [3](#Tab3){ref-type="table"}).Table 2Patient characteristicsCharacteristicsNo. (%)Age (mean ± SD)62.28 ± 12.45Males757 (69.76)*Ethnicity*604 (55.66)Caucasians131 (12.07)Hispanic41 (3.77)African Americans95 (8.75)Asians33 (3.04)Others181 (16.68)Unknown56.72 ± 9.43HR at the time of scan (mean ± SD)752 (69.3)HR ≤ 60 beats/min145 (13.36)Diabetes Mellitus type II386 (35.57)Hypertension338 (31.15)Dyslipidemia424 (39.07)Family history of CAD582.64 ± 978.66CAC score (mean ± SD)26.3 ± 4.2Body mass index (kg/m^2^) (mean ± SD)168 (15.48)Obstructive disease (\>50%) on the CCTATable 3The distribution of optimal images (Grades 1 and 2, total 1,071 images) among varying heart rate groupsHeart rate (beats/min)Phase of RR interval30--4041--4546--5051--5556--6061--6566--70\>7035%NANANA2.642.265.135.412.8645%NANANANA2.266.418.1122.8655%NA1.960.600.76NA0.642.7022.8665%NA1.962.985.283.553.214.05NA75%91.6794.1296.4390.1990.6583.3374.3242.8685%8.33NANA0.760.970.641.352.8695%NA1.96NA0.380.320.644.055.71*N*12511682653101567435

Utilizing 75% phase of the R--R interval to capture images for HR \< 60 gave an interpretable image quality in 93.2% of the patients (*P* ≤ 0.001), while using 4-phase \[35% + 45% + 55% + 75%\] for HR \> 60 bpm gave an interpretable image in 92.4% of the patients (*P* = 0.0001) \[Interpretable image: Grades 1 and 2\]. Figure [2](#Fig2){ref-type="fig"} and Table [4](#Tab4){ref-type="table"}, shows the two models (75% phase and 4 phases \[35% + 45% + 55% + 75%\]) created to assess the ability of the R--R interval to predict interpretable images in 64 slice MDCT. The area under the curve (AUC) for optimal images for HR \> 60 bpm was 0.77 ± 0.04 \[95% CI: 0.61--0.87, *P* = 0.008\] in 75% phase. For HR \> 60 bmp, the AUC for optimal images in phases 35% + 45% + 55% + 75% of RR interval combined was 0.92 ± 0.02 \[95% CI: 0.83--0.96, *P* ≤ 0.001\].Fig. 2ROC curves for two models created to assess the ability of the R--R interval phases to predict interpretable CTA using 64 MDCT in patients with HR \> 60 bpmTable 4Area under the curve (AUC) for patients with HR \< 60 in 75% phase and for HR \> 60 in multiphase image reconstruction (phase 35, 45, 55, 65 and 75)ModelAUC (±SE)95% CI*P*Phase 75% @ HR \< 60 bpm0.77 (0.04)0.61--0.870.008Phase 35, 45, 55 and 75% @ HR \> 60 bpm0.92 (0.02)0.83--0.960.0001

Comparison of ejection fraction utilizing 75% phase as end-diastole vs. 95% phase of the RR interval {#Sec9}
----------------------------------------------------------------------------------------------------

In this group, 63.4% (137/216) were males, 2.3% (5/216) were smokers, 20.8% (45/216) were diabetic, 32.4% (70/216) had dyslipidemia, 44.4% (96/216) were hypertensive and 52.3% (113/216) had a family history of CAD.

Of the parameters tested for an association with EDV, we found LV volume at 75% phase, age, weight, height, heart rate, and LV mass to be correlated with EDV. Two-tailed *t*-tests were performed on the difference between the mean EDV of several subgroups of patients (Table [5](#Tab5){ref-type="table"}). A similar analysis was performed to identify predictors of LVEF (Table [6](#Tab6){ref-type="table"}).We then incorporated all the variables that were found to be associated with EDV and LVEF into two multivariable linear regression analyses: one studied the correlation of these variables with EDV and the other with LVEF. The following formulas were the outcomes of the analyses:Table 5Predictors of EDVParameters*P* value*Univariate predictors of EDVr*LV volume at 75% phase0.964\<0.001Age−0.354\<0.001Weight0.322\<0.001Height0.333\<0.001Heart rate−0.1430.035LV mass0.467\<0.001Mean EDV ratioMale/Female112.91/96.49\<0.001DM (Yes/No)99.53/108.580.059DL (Yes/No)98.46/110.540.001*Multivariate predictors of EDV*Odds ratioLV volume at 75% phase0.951\<0.001Heart rate0.0480.018LV mass0.0480.022Table 6Predictors of LVEF (95_35)Parameters*P* value*Univariate predictors of LVEFr*LVEF (75_35)0.930\<0.001Age0.243\<0.001Weight−0.0930.174Height−0.1390.042Heart rate−0.1060.121LV mass−0.0220.765Mean LVEF ratioDM (Yes/No)68.34/66.010.07Male/Female65.30/68.58\<0.001HTN (Yes/No)67.92/65.500.024*Multivariate predictors of LVEF*Odds ratioLVEF (75_35)0.940\<0.001Heart rate0.096\<0.001Age0.103\<0.001EDV = \[1.048 × (LV volume 75%)\] + \[0.014 × (LV mass)\] + (0.223 × heart rate) − 14.83 (Adj. *R*^2^ 0.94, *P* \< 0.001)LVEF = \[0.78 × LVEF (75_35)\] + (0.12 × heart rate) + (0.066 × age) + 10.47 (Adj. *R*^2^ 0.89, *P* \< 0.001)

To further analyze our regression models, we studied the residuals and their variance. We transformed the regression residuals to standardized residuals and then constructed a histogram plot that showed normal distribution of standardized residuals. Figure [3](#Fig3){ref-type="fig"} is a scatterplot of the studentized residuals for the dependent variable LVEF using 95 and 35% phases versus the standardized predicted value for that regression model. Figure [4](#Fig4){ref-type="fig"} is a similar scatterplot for dependent variable LV volume at 95% phase. Both scatter plots show that the residuals have a random distribution around zero and that the degree of scatter appears constant across the predicted values. Considering use in daily clinical practice, we also derived abridged versions of the above 2 formulas and plotted their corresponding graphs (Figs. [5](#Fig5){ref-type="fig"}, [6](#Fig6){ref-type="fig"}).Fig. 3Scatteplot of studentized residuals vs. standardized residuals for the regression model of LV volume 95 vs. 75% phaseFig. 4Scatterplot of studentized residuals vs. standardized predicted value for regression model of LVEF (95_35) vs. LVEF (75_35)Fig. 5Predicting EDV. Abridged plot of the linear regression model comparing left ventricular volume using 95% phase (*y*-axis) vs. 75% phase (*x*-axis)Fig. 6Predicting LVEF. Abridged plot of the linear regression model comparing LVEF 95_35 vs. LVEF 75_35

Abridged formulas:EDV = 1.064 × (LV volume at 75%) + 14.43 (Adj. *R*^2^ linear = 0.94, *P* \< 0.001)LVEF = 0.782 × LVEF (75_35) + 20.76 (Adj. *R*^2^ 0.87, *P* \< 0.001).

Discussion {#Sec10}
==========

Minimizing radiation exposure through ECG triggered X-ray tube activation is a step towards making coronary CTA safer. Using the RS-OHA technique, where the X-ray beam is continuously on, all phases of the cardiac cycle are available. Using the SSPA technique where the X-ray beam is on only at targeted points of the RR interval significantly decreases the radiation exposure, but does not allow for end-diastole (95th percentile) to be obtained \[[@CR1], [@CR10], [@CR11]\]. Selecting the targeted intervals that produce the best image quality is HR dependent. In our study we reviewed coronary CTAs performed by 64-MDCT on 1,085 patients to determine optimum phases of R--R interval in regards to image quality at varying heart rates. We found that, whereas targeting the 75% phase of the cardiac cycle (R--R interval) produced \>90% of the best image quality at HR \< 60 bpm, heart rates of \>60 and \<70 bpm reduced the frequency of optimal image quality to 84%, and HR \> 70 bpm decreased it further to 43%. Furthermore, at HR \> 60 bpm, a significant proportion of best image quality is produced at the 35, 45 and 55% phases of the R--R interval. Hence, based on our results, for patients with HR \> 60 bpm reconstructing images at the 35, 45, 55 and 75% phases produced interpretable images in 92% of the cases.

Coronary artery motion, among others, remains to be a significant cause of artifact in images produced by 64-MDCT \[[@CR12]\]. Peak velocities of motion were found to be caused by ventricular systole, diastole and atrial contraction. Among the 3 epicardial vessels, the RCA displayed the highest mean motion velocity (50--69.5 mm/s) followed by the left circumflex, then the left anterior descending \[[@CR13], [@CR14]\]. Not surprisingly, since coronary motion is primarily determined by ventricular and atrial motion, coronary motion increases with increasing HR. Moreover, with increasing HR all the phases of the cardiac cycle are affected to varying degrees; thus shifting the coronary motion velocity peaks and troughs \[[@CR14]\]. To further support this observation, in a previous EBCT study, Mao et al. \[[@CR3]\] showed that among the various segments of the R--R interval, TR (ventricular diastole) and TP (ventricular diastole (TR) excluding PR duration) were subjected to the most variation in comparison to PR (from beginning of P wave to R peak) and RT segments (from R peak to the end of T wave) in electrocardiogram (ECG) with increasing HR. Hence, whereas at HR \< 60 bpm RCA motion velocity is minimal at 75% phase, at HR \> 60 bpm minimal RCA motion velocity is seen at earlier phases closer to "ventricular systole" (35 and 45% R--R interval phases). In line with the latter observation, our results showed better RCA image quality in the 45 and 55% interval phases for patients with HR \> 70 bpm. Brodoefel et al. \[[@CR15]\] in their study involving 100 patients without heart rate control concluded that along with calcification, heart rate variability significantly impairs image quality of coronary vessels while using Dual-source CT. A similar study \[[@CR4]\] on 60 patients but with HR \< 75 bpm showed no significant difference in image quality score for the total coronary segments comparing SSAP CT angiography to RS-OHA CT angiography. Earls et al. \[[@CR16]\], in a cohort of 203 patients (82 underwent RS-OHA CT and 121 underwent SSPA) and HR \< 70 bpm, found comparable image quality with the 2 techniques but with reduced radiation exposure in SSPA. Frydrychowicz et al. \[[@CR17]\], suggested that the '60% phase' portrayed the best image quality in HR controlled patients while Leschka et al. \[[@CR18]\], on 125 patients obtained best image quality in the 50--80% range of the R--R interval in \>50% of the coronary segments. The best reconstruction time shifted to end systole (25--40% of the R--R interval) with higher HR. Pannu et al. \[[@CR19]\] in a group of 50 patients with a mean HR of 59.8 bpm. Have shown that 70% phase produces the best images and that the mid-RCA is the most affected segment by cardiac motion. Based on this, we suggest that for patients undergoing 64-MDCT and with a HR \> 60 bpm, either retrospective triggering or snap shot pulse acquisition (SSPA) with a wide range of acquisition be applied (35--75%).

In the present study in a smaller cohort of 216 patients with EF \> 50% and no evidence of MI, we showed that that LV volume measured at the 75% phase can serve as surrogate for EDV (LV volume at 95% phase), and therefore be used to calculate LVEF with reasonable accuracy. EDV is associated with several parameters, however, only LV volume at 75%, LV mass and heart rate remained as statistically significant independent predictors of EDV in a multivariable linear regression analysis. We therefore derived two equations for estimating EDV and LVEF: a comprehensive equation including LV volume at the 75% phase, heart rate and LV mass; and an abridged form that includes only LV volume at the 75% phase which we believe will be easier to use in a clinical setting. A significant radiation dose reduction can be obtained by performing prospectively triggered scans in comparison to retrospective ECG-gated CT scan with dose modulation for functional evaluation. For example, in a study using dual source CT scan, an average radiation dose was 9.0 mSv for the retrospective CT protocol with dose modulation vs. 2.9 mSv for the prospective CT protocol (both use 120 kV and result in similar image quality). Therefore, using two prospective scans against one retrospective scan would give approximately 36% dose reduction (5.8 vs. 9.0 mSv) \[[@CR20]\].

End diastolic volume is achieved at the end of diastolic filling, which starts at mitral valve opening and ends at mitral valve closure. Since the diastolic period is characterized by early filling (E), diastasis and late filling (A---atrial kick dependent) phases, then the volume of blood in the LV at 75% is essentially dependent on where the 75% time point is relative to the subsequent diastolic phases. The well known predictors of E and A are: age, gender, LV hypertrophy \[[@CR21]\], ischemic disease \[[@CR22]\], DM type 2 (independent of LVH), valvular heart disease, heart rate (which includes intrinsically the QT, TP and PR intervals) \[[@CR23]\] and preload \[[@CR24]\]. These variables were mostly reported to be predictors of LV volume at the 95% phase (EDV), but not all of them were found to be statistically significant independent predictors in our final regression equation. Several reasons can account for this. One reason is that the more subtle or weaker associations may not have become apparent due to the small sample size (*N* = 216). We note that whereas Doppler echocardiography remains the reference standard to derive E and A velocities \[[@CR25]\], echo derivation of LV mass is limited with the need for mathematical model assumptions \[as evidenced by cardiac magnetic resonance imaging (MRI)\] \[[@CR26]\]. Contrastingly, previous studies have shown that cardiac CT can accurately quantify LV mass and volumes compared with cardiac \[[@CR27]--[@CR29]\] MRI.

Limitations {#Sec11}
===========

Our study has some limitations. We looked at RCA to access motion and predicted the interpretability of the study. The circumflex coronary artery is the second most common artery affected by motion, and this was not assessed in this study. We acquired images at 10% intervals, some studies have constructed the images at 5% of intervals but experience at our center has not seen any added benefit of further segmentation of image sets.

We did not separately include the QT, TP and PR intervals in our regression model for ejection fraction calculation. Failing to include these intervals is a limitation that is a consequence of the study's retrospective design. Several groups, including ours, have demonstrated that with heart rate variation these intervals are affected to varying degrees \[[@CR3]\], and therefore the 75% time point of the RR-interval might vary as well. Additionally, given that ECG documentation was not available to include in our analysis, we cannot make note of the presence of a conduction problem that could have impacted our results (e.g. first degree atrio-ventricular block).

It should also be mentioned that the CCTA protocol includes giving beta blockers and nitrates (100% of our cohort received both), which can further affect both heart rate and preload. However, this is the standard protocol used at most centers. Additionally, our results cannot be extrapolated to patients with heart failure (LV EF \< 50%) or evidence of MI (aneurysms in particular).

Not all the patients can be scanned using prospective---ECG triggered CT image acquisition e.g. in patients with atrial fibrillation. The maximum dose saving is achieved using the shortest acquisition window, which does not allow any flexibility in post-acquisition phase adjustment. This can potentially result in sub-optimal image quality and compromise the diagnostic value of the exam. The LVEF (75_35) values calculated from a retrospective ECG-gated scan and two prospective scans triggered at 35 and 75% of the R--R interval are not going to be necessarily the same, especially for patients with some heart rate variability. An ideal study design should compare the "true LVEF(75_35)" calculated from the two prospective scans with a "gold standard LVEF" calculated from the best end-systolic and best end-diastolic phases obtained using either retrospective CT or MRI. This study would be hard to conduct using retrospective CT due to exponential radiation exposure in human beings.

Conclusions {#Sec12}
===========

We demonstrate in a cohort of 1,085 patients that the optimal RCA image quality using a 64 MDCT scanner is heart rate dependent. For HR \< 60 bpm the 75% phase of the R--R interval should provide adequate image quality in more than 90% of the cases. However, short of better HR control, when the HR is \>60 bpm acquiring 4 phases (75, 35, 45 and 55%) will produce an interpretable study in \>90% of CT angiographies. While using dose-modulation protocols in CCTA to reduce radiation exposure in order to estimate EDV and LV EF, we should aim to acquire both the 35 and 75% phases.

Thus, prospective acquisition protocols that obtain two phases (35 and 75%) will allow for motion free images of the coronary arteries and will potentially estimate EF in all patients suitable for prospective triggering. Future prospectively designed large-scale studies aimed at eliminating some, if not all, of the above cited limitations can be extremely useful and promising.
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